| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.80B | 8.98B | 12.80B | 12.73B | 10.41B | 9.85B |
| Gross Profit | 4.18B | 4.13B | 4.58B | 4.20B | 3.15B | 3.04B |
| EBITDA | 228.14M | 342.52M | 467.44M | 672.79M | 671.35M | 938.87M |
| Net Income | -4.53M | 117.69M | 199.63M | 346.77M | 390.72M | 621.73M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 9.03B | 8.74B | 8.56B | 7.55B | 6.83B |
| Cash, Cash Equivalents and Short-Term Investments | 4.13B | 4.23B | 3.36B | 1.38B | 2.15B | 1.96B |
| Total Debt | 0.00 | 127.60M | 46.98M | 67.83M | 73.56M | 102.27M |
| Total Liabilities | -7.41B | 1.62B | 1.72B | 1.75B | 1.47B | 1.25B |
| Stockholders Equity | 7.41B | 7.41B | 7.01B | 6.81B | 6.08B | 5.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 513.66M | 1.25B | -576.57M | 292.02M | 771.81M |
| Operating Cash Flow | 0.00 | 514.92M | 1.26B | -520.73M | 449.63M | 802.23M |
| Investing Cash Flow | 0.00 | 157.48M | 682.98M | -628.59M | -314.57M | -14.27M |
| Financing Cash Flow | 0.00 | -34.55M | -37.42M | -28.16M | -56.37M | -45.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹2.29B | 30.88 | ― | 0.84% | -10.39% | -52.44% | |
66 Neutral | ₹1.33B | 1.95 | ― | 0.49% | 30.15% | 330.45% | |
66 Neutral | ₹2.16B | 11.07 | ― | ― | 20.62% | 1.68% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ₹1.56B | 40.00 | ― | ― | -16.31% | -9.79% | |
56 Neutral | ₹1.34B | 64.01 | ― | 0.26% | 9.12% | 22.53% | |
55 Neutral | ₹2.82B | 4.37 | ― | ― | -6.88% | ― |
Trigyn Technologies Limited has announced that it will close its trading window for designated persons, their immediate relatives and other insiders from 1 January 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s internal code of conduct. The restriction, which includes freezing the PANs of designated persons by NSDL, is tied to the preparation and approval of the company’s unaudited financial results for the quarter ended 31 December 2025, and will remain in force until 48 hours after these results are disclosed to the stock exchanges, underscoring the company’s efforts to ensure compliance and prevent insider trading ahead of a key earnings announcement.